Latest News

Flaw in Alzheimer's drug trial test, research suggests

New research suggests that the cognitive test used in Alzheimer's drug trials is flawed. They believe that the flaw lies behind the failure and withdrawal of a number of trials around the world, and they call for the current test to be replaced with a method that is fit for purpose.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Public Health Responsibility Deal in UK unlikely to be an effective response to alcohol harms

  • Immunotherapy used to reduce memory problems with Alzheimer's disease

  • How the brain 'remembers' pain

  • Calcium channels play a role in neuronal homeostasis, elimination of toxic buildup of proteins

  • Love the cook, love the food: Attraction to comfort food linked to positive social connections

  • Intergenerational transmission of abuse and neglect more complicated than previously believed

  • Researchers identify timeline for HIV replication in the brain

  • New autism-causing genetic variant identified

  • The brain in the supermarket: Index strategy informs decision-making

  • Boredom can be good for you, scientists say

  •